METABOLIC ABNORMALITIES IN STARVATION DIABETES

METABOLIC ABNORMALITIES IN STARVATION DIABETES

Defining the Relationship Between Plasma Glucose and HbA1c Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial

Defining the Relationship Between Plasma Glucose and HbA1c Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial

A low-carbohydrate, ketogenic diet to treat type 2 diabetes

A low-carbohydrate, ketogenic diet to treat type 2 diabetes

The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus

The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus

The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus

The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus
(abstract only)

The Fat Controller: Adipocyte Development

The Fat Controller: Adipocyte Development

Some Prospective Studies T2 Predictive Markers

1. Minimal Contribution of Fasting Hyperglycemia to the Incidence of Type 2 Diabetes in Subjects With Normal 2-h Plasma Glucose
2. What Is the Best Predictor of Future Type 2 Diabetes?
3. Inflammation markers and metabolic characteristics of subjects with one-hour plasma glucose levels
4. Fasting Versus Postload Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes
5. One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes

Gastrin Stimulates Cell Neogenesis and Increases Islet Mass ...

Gastrin Stimulates

Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations

Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations

The role of protein kinase C activation in diabetic nephropathy

The role of protein kinase C activation in diabetic nephropathy

Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis

Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis

Proteins altered by elevated levels of palmitate or glucose implicated in impaired glucose-stimulated insulin secretion

Proteins altered by elevated levels of palmitate or glucose implicated in impaired glucose-stimulated insulin secretion

Mathematical Model of Metabolism and Electrophysiology of Amino Acid and Glucose Stimulated Insulin Secretion: In Vitro Validation Using a β-Cell Line

Mathematical Model of Metabolism and Electrophysiology of Amino Acid and Glucose Stimulated Insulin Secretion: In Vitro Validation Using a β-Cell Line

Altered Insulin Receptor Signalling and β-Cell Cycle Dynamics in Type 2 Diabetes Mellitus

Altered Insulin Receptor Signalling and β-Cell Cycle Dynamics in Type 2 Diabetes Mellitus

Diabetes, cancer, and metformin: connections of metabolism and cell proliferation

Diabetes, cancer, and metformin: connections of metabolism and cell proliferation

Nonalcoholic fatty pancreas disease

Nonalcoholic fatty pancreas disease

Is Weight Loss a Cure for Type 2 Diabetes? (2002)

Is Weight Loss a Cure for Type 2 Diabetes?

25 Years Progress in Type 2 Diabetes

[PDF] 

25 Years Progress in Type 2 Diabetes

C-Peptide as a Therapeutic Tool in Diabetic Nephropathy

C-Peptide as a Therapeutic Tool in Diabetic Nephropathy

Osteoporosis: An Under-appreciated Complication of Diabetes

Osteoporosis: An Under-appreciated Complication of Diabetes